NEW YORK (GenomeWeb) – The Parkinson's Institute and Clinical Center announced on Friday a collaboration with Germany's Centogene on panel-based genetic screening for a US patient cohort.

Under the partnership, patients will be screened using a large, customized panel to characterize genetic variants associated with development and treatment of Parkinson's disease.